Sage Journals: Discover world-class research

Open access

Review article

First published 2025

Emerging roles of SLAMF7 in immune cells and related diseases

Zheng Zhang, Ying Zhang, Zeyu Chen [...]

Innate Immunity

Open access

Review article

First published 2016-10

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab

Hermann Einsele, Martin Schreder

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2020-03-10

Genome-Wide Association Study Identifies SLAMF1 Affecting the Rate of Memory Decline

Shi-Dong Chen, Hong-Qi Li, Xue-Ning Shen [...]

Journal of Alzheimer’s Disease

Retricted access

Research article

First published 2014-08

Development and Characterization of Domain-Specific Monoclonal Antibodies Produced Against Human SLAMF9

Olga Volkova, Sergey Guselnikov, Ludmila Mechetina [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Open access

Research article

First published 2025-10

SLAMF8 expression and prognostic significance in melanoma: A multi-omics and Mendelian randomization study

Jianjiang Liu, Wei Han, Guoliang Shen

Cancer Biomarkers

Open access

Research article

First published 2025-7

Assessing Genetic Risk of DKK3 and SLAMF6 in Erectile Dysfunction: A Comprehensive Analysis Based on Mendelian Randomization

Guangqiang Zhu, Chunlin Tan, Yugen Li

American Journal of Men's Health

Retricted access

Research article

First published 2015-10

Analysis of expression and function of the co-stimulatory receptor SLAMF1 in immune cells from patients with systemic lupus erythematosus (SLE)

L Liñán-Rico, B Hernández-Castro, L Doniz-Padilla [...]

Lupus

Free access

Review article

First published 2016-8

Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment

Hila Magen, Eli Muchtar

Therapeutic Advances in Hematology

Retricted access

Review article

First published 2016-7

Immunotherapy

Salma Afifi, Angela Michael, Alexander Lesokhin

Annals of Pharmacotherapy

Search results